Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD5069 for coronary heart disease after PCI
ISRCTN48328178Phase 2Terminated
- Sponsor
- King's College London
- Start
- Jun 2016
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in coronary arteriosclerosis comparing AZD5069 with Placebo (2 arms). Primary endpoint: Change in coronary flow reserve. Started Jun 2016; status: terminated.
02
Drugs
azd5069
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ISRCTN48328178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN48328178.